Related Experiment Videos
Tranexamic acid in acute upper gastrointestinal bleeding.
1Dept. of Surgery, Länssjukhuset, Halmstad, Sweden.
Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1987
Summary
Tranexamic acid, an antifibrinolytic, reduces mortality in acute upper gastrointestinal bleeding. While transfusion and operation rates varied, its use is indicated for this condition.
Area of Science:
- Pharmacology
- Gastroenterology
- Clinical Trials
Background:
- Acute upper gastrointestinal bleeding is a significant medical condition.
- Antifibrinolytic agents are used to control bleeding.
Purpose of the Study:
- To evaluate the efficacy of tranexamic acid in acute upper gastrointestinal bleeding.
- To analyze its impact on mortality, transfusion needs, and surgical intervention.
Main Methods:
- Systematic review of 5 double-blind, randomized, placebo-controlled trials.
- Analysis of patient outcomes including mortality, blood transfusions, and operations.
Main Results:
- Consistent reduction in mortality observed in patients treated with tranexamic acid.
- Varied results regarding blood transfusion requirements and frequency of operations across studies.
Conclusions:
- Tranexamic acid demonstrates a clear benefit in reducing mortality in acute upper gastrointestinal bleeding.
- Its indication in managing this condition is supported by the collective evidence.